Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on October 28, 2026

Oct. 28, 2026

شركة AdipoPharma تُحرز تقدمًا في تطوير دواء PATAS من خلال الانتقال إلى المرحلة 1b من التجارب السريرية على مرضى السكري من النوع الثاني.

Indeterminate GlobeNewswire

Oct. 28, 2026

AdipoPharma startet klinische Phase-1b-Studie mit PATAS bei Patienten mit Typ-2-Diabetes

Indeterminate GlobeNewswire

Oct. 28, 2026

AdipoPharma lance la phase 1b des essais cliniques du peptide PATAS chez des patients atteints de diabète de type 2

Indeterminate GlobeNewswire

Oct. 28, 2026

WTW 2026 Best Practices in Healthcare Survey: U.S. employer healthcare costs set to rise at fastest pace in more than two decades

Indeterminate GlobeNewswire

Oct. 28, 2026

Medicana Health Group Introduces Digital Twin-Based Dental Treatment Planning

Indeterminate GlobeNewswire

Oct. 28, 2026

Flexi Yoga App Launches Personalized Flexibility and Mobility App

Indeterminate GlobeNewswire

Oct. 28, 2026

$20,000 donated by Saskatchewan Blue Cross to six local organizations

Indeterminate GlobeNewswire

Oct. 28, 2026

Novato-based Live Oaks Wellness encourages year-round prevention with family engagement and community-based prevention efforts for substance abuse

Indeterminate GlobeNewswire

Oct. 28, 2026

New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits

Indeterminate GlobeNewswire

Oct. 28, 2026

DoStance App Launches Personalized Posture App With Guided Daily Exercises

Indeterminate GlobeNewswire

Oct. 28, 2026

Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer

Indeterminate GlobeNewswire

Oct. 28, 2026

Applied Biologics Announces Publication of Peer-Reviewed CAMPX Interim Trial Results in the Journal of Chronic Wound Care Management & Research

Indeterminate GlobeNewswire

Oct. 28, 2026

Vivex Biologics' VIA Disc® NP Meets Primary Endpoint in Pivotal, Sham-Controlled ASCEND Trial Published in Journal of Clinical Medicine

Indeterminate GlobeNewswire

Oct. 28, 2026

NTHU Study Reveals Dual Mechanism of Neural Repair After Brain Injury: Plant Compound Promotes Neurite Regrowth and Reduces Oxidative Stress

Indeterminate GlobeNewswire

Oct. 28, 2026

Longeveron Announces Engagement of Lucid Capital Markets

Indeterminate GlobeNewswire

Oct. 28, 2026

Digital Wellness Launches Protein Calculator for Mayo Clinic Diet to End the Guesswork Around Daily Protein Needs

Indeterminate GlobeNewswire

Oct. 28, 2026

Athelas Named Diamond Sponsor of the 2026 APTA Private Practice Annual Conference, Deepening Its Commitment to the Physical Therapy Profession

Indeterminate GlobeNewswire

Oct. 28, 2026

LiveWorld Appoints Rema Judeh as Vice President of Account Management

Indeterminate GlobeNewswire

Oct. 28, 2026

Houston VA Study Reports Increased Quantitative Monitoring with TwitchView®; Separate Study Shows Near-Zero Bias Versus Gold Standard Mechanomyography, Both Presented at ANESTHESIOLOGY® 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

Nacuity Pharmaceuticals Announces First Patient Dosed in Global Confirmatory Phase 3 Trial of NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa Associated with Usher Syndrome

Indeterminate GlobeNewswire